Table 3 Factors associated with delay in diagnosis of cancer among children aged ≤ 18 years (UOGCSH), 2022(N = 200)

Sex

Female

25(36.23%)

44(63.77%)

0.61(0.34–1.12)*

1.14(0.13–9.97)

Male

63(48.09%)

68(51.91%)

1

1

Residence

Rural

42(55.26%)

34(44.74%)

2.09(1.17–3.74)*

1.96(1.08–3.58)**

Urban

46(37.1%)

78(62.9%)

1

1

Health insurance

Yes

30(34.09%)

58(65.91%)

1

1

No

58(51.79%)

54(48.21%)

2.1(1.17–3.69)*

2.21(1.21–4.04)**

Comorbid disease

Yes

30(35.29%)

55(64.71%)

1

1

No

58(50.43%)

57(49.57%)

1.9(1.05–3.32)*

2.1(1.01–4.32)**

Cancer type

HL

12(80%)

3(20%)

9(2.23–36.33)*

9.4(2.1-41.72)**

NHL

13(46.43%)

15(53.57%)

1.84(0.71–4.77)*

1.54(0.54–4.38)

Wilms

19(51.35%)

18(48.65%)

2.24(0.93–5.39)*

1.53(0.63–4.27)

Retinoblastoma

14(68.18%)

8(31.82%)

3.94(1.38–11.25)*

4.1(1.29–13.03)**

ALL

16(32%)

34(68%)

1

1

Referral

Yes

9(21.43%)

33(78.57%)

1

1

No

79(50%)

79(50%)

3.7(1.65–8.16)*

6.3(2.15–18.55)**